Bio-Rad Laboratories's market cap is currently $8.08B. The company's EPS TTM is $-65.036; its P/E ratio is ―; Bio-Rad Laboratories is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $1.85. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 2.57B	$ 2.67B	$ 2.80B	$ 2.92B	$ 2.55B
Gross Profit	$ 1.38B	$ 1.43B	$ 1.57B	$ 1.64B	$ 1.44B
Operating Income	$ 269.00M	$ 337.80M	$ 482.62M	$ 489.43M	$ 410.96M
EBITDA	$ -2.14B	$ -608.26M	$ -4.49B	$ 5.63B	$ 5.10B
Net Income	$ -1.84B	$ -637.32M	$ -3.63B	$ 4.25B	$ 3.81B
Balance Sheet
Cash & Short-Term Investments	$ 1.18B	$ 1.61B	$ 1.80B	$ 875.48M	$ 996.68M
Total Assets	$ 9.36B	$ 12.30B	$ 13.50B	$ 17.78B	$ 12.97B
Total Debt	$ 174.30M	$ 1.41B	$ 1.20B	$ 11.00M	$ 14.06M
Net Debt	$ 174.30M	$ 1.00B	$ 763.97M	$ -459.78M	$ -648.15M
Total Liabilities	$ 2.79B	$ 3.56B	$ 3.89B	$ 4.11B	$ 3.09B
Stockholders' Equity	$ 6.57B	$ 8.74B	$ 9.62B	$ 13.67B	$ 9.88B
Cash Flow
Free Cash Flow	$ 266.20M	$ 218.26M	$ 80.29M	$ 535.72M	$ 476.41M
Operating Cash Flow	$ 455.20M	$ 374.94M	$ 194.45M	$ 656.52M	$ 575.33M
Investing Cash Flow	$ -160.20M	$ 20.21M	$ -1.21B	$ -784.44M	$ -60.25M
Financing Cash Flow	$ -218.80M	$ -425.65M	$ 973.58M	$ -55.43M	$ -523.04M

Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

Income Statement >

Bio-Rad Laboratories Debt to Assets

Balance Sheet >

Bio-Rad Laboratories Cash Flow

Cash Flow >

Bio-Rad Laboratories Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing